Drug treatment of clinical problems related to cardiac transplantation.
In recent years, several new immunosuppressive agents have become available for the treatment of cardiac transplant recipients. Use of these agents and their potential side effects are reviewed.
Hankins
Shelley
S
Department of Medicine, Division of Circulatory Physiology, Columbia Presbyterian Hospital Center, New York, New York, USA.
Mancini
Donna
D
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000209:etiology / Q000601:surgery; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000188:drug therapy; D006084:Graft Rejection / Q000517:prevention & control; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy; D006973:Hypertension / Q000139:chemically induced / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007674:Kidney Diseases / Q000139:chemically induced / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000209:etiology; D009369:Neoplasms / Q000209:etiology
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents